| 3,3 Disubstituted 19-nor pregnane compounds, compositions, and uses thereof |
2023-6-26 |
2023-7-13 |
|
| Neuroactive steroids and their methods of use |
2023-6-13 |
2023-10-12 |
|
| DEUTERATED 21-[4-CYANO-PYRAZOL-1-YL]-19-NOR-PREGAN-3.α-OL-20-ONE DERIVATIVES … |
2023-6-06 |
2023-7-28 |
|
| Cyp46a1 inhibitors and methods of use thereof |
2023-5-25 |
2023-10-05 |
|
| Neuroactive steroids, compositions, and uses thereof |
2023-5-15 |
2023-6-01 |
|
| Neuroactive steroids, compositions, and uses thereof |
2023-4-28 |
2023-7-04 |
|
| Oxysterols and methods of use thereof |
2023-3-16 |
2023-5-09 |
|
| Neuroactive 19-alkoxy-17-substituted steroids, prodrugs thereof, and methods of … |
2023-3-07 |
2023-5-23 |
|
| Compositions and methods for treating CNS disorders |
2023-3-02 |
2023-5-23 |
|
| 19-nor c3,3-disubstituted c21-n-pyrazolyl steroid and methods of use thereof |
2023-3-01 |
2023-6-29 |
|
| FORMULATIONS OF THE STEROID C21-N-PYRAZOLYL 19-NOR C3,3-DISUBSTITUTED AND … |
2023-2-17 |
2023-3-31 |
|
| Compositions and methods for treating cns disorders |
2023-2-16 |
2023-6-22 |
|
| Neuroactive steroids for treatment of cns-related disorders |
2023-2-15 |
2023-8-24 |
|
| Neuroactive steroids for treatment of gastrointestinal diseases or conditions |
2023-2-15 |
2023-8-31 |
|
| Neuroactive steroids for treatment of cns-related disorders |
2023-2-15 |
2023-8-24 |
|
| Neuroactive steroids for treatment of gastrointestinal diseases or conditions |
2023-2-15 |
2023-8-31 |
|
| Neuroactive steroids for treatment of gastrointestinal diseases or conditions |
2023-2-15 |
2023-8-31 |
|
| Neuroactive steroids for treatment of gastrointestinal diseases or conditions |
2023-2-15 |
2023-8-31 |
|
| Oxysterols and methods of use thereof |
2023-2-06 |
2023-10-19 |
|
| Neuroactive steroids and use methods thereof |
2023-1-18 |
2023-3-10 |
|
| Nerve-activating steroid solution and method for using the same |
2023-1-05 |
2023-2-24 |
|
| Oxysterols and methods of use thereof |
2022-12-19 |
2023-2-02 |
|
| Combination of muscarinic receptor positive modulators and nmda positive … |
2022-12-13 |
2023-6-22 |
|
| Neuroactive steroid for the treatment of huntington's disease |
2022-12-12 |
2023-6-22 |
|
| Compositions and methods for treating CNS disorders |
2022-11-28 |
2023-2-14 |
|
| Neuroactive steroids and methods of use thereof |
2022-11-28 |
2023-1-19 |
|
| Crystalline 19-nor c3,3-disubstituted c21-n-pyrazolyl steroids |
2022-11-07 |
2023-1-10 |
|
| Oxysterols and methods of use thereof |
2022-10-30 |
2022-12-01 |
|
| Neuroactive steroids, compositions, and uses thereof |
2022-9-26 |
2023-9-07 |
|
| Use of agents for the treatment of respiratory conditions |
2022-9-26 |
2022-10-11 |
|
| Deuterated positive nmda-modulating compounds and methods of use thereof |
2022-9-22 |
2023-3-30 |
|
| Neuroactive compounds and methods of use thereof |
2022-9-19 |
2023-7-13 |
|
| Neuroactive steroids and compositions thereof |
2022-9-02 |
2023-8-10 |
|
| Positive nmda-modulating compounds and methods of use thereof |
2022-8-25 |
2023-4-20 |
|
| Crystalline forms of a neuroactive steroid |
2022-7-28 |
2023-6-01 |
|
| C17, C20, and C21 substituted neuroactive steroids and their methods of use |
2022-7-26 |
2022-8-18 |
|
| Neuroactive steroid formulations and methods of treating cns disorders |
2022-7-20 |
2023-5-18 |
|
| Method of treating cns disorders with neurosteroids and gabaergic compounds |
2022-7-18 |
2023-4-13 |
|
| 19-nor C3,3-disubstituted C21-N-pyrazolyl steroids and methods of use thereof |
2022-7-12 |
2022-7-28 |
|
| Neuroactive steroids, compositions, and uses thereof |
2022-7-12 |
2022-9-21 |
|
| Oxysterols and methods of use thereof |
2022-7-08 |
2023-5-04 |
|
| Oxysterols and methods of use thereof |
2022-7-01 |
2022-9-06 |
|
| Methods of treating epilepsy or status epilepticus |
2022-6-26 |
2022-8-01 |
|
| Neuroactive steroids, compositions, and uses thereof |
2022-6-17 |
2022-8-04 |
|
| 19-nor c3,3-disubstituted c21-n-pyrazolyl steroid and methods of use thereof |
2022-6-17 |
2022-10-13 |
|
| Neuroactive steroid for the treatment of alzheimer's disease |
2022-6-10 |
2022-12-15 |
|
| Oxysterols and methods for use thereof |
2022-6-08 |
2022-8-17 |
|
| Oxysterols and methods of use thereof |
2022-6-03 |
2022-7-22 |
|
| A 19-nor c3,3-disubstituted c21-n-pyrazolyl steroid and methods of use thereof |
2022-6-01 |
2022-8-01 |
|
| Method for preparing a solid crystalline form a of a compound of formula 1. … |
2022-5-20 |
2023-3-10 |
|
| Neuroactive steroid for the treatment of mild cognitive impairment associated … |
2022-5-04 |
2022-11-10 |
|
| 19-nor c3,3-disubstituted c21 -n-pyrazolyl steroid for use in treating major … |
2022-4-29 |
2022-11-03 |
|
| Neuroactive steroid for use in treating major depressive disorder and … |
2022-4-29 |
2022-11-03 |
|
| 19-nor c3,3-disubstituted c21 -n-pyrazolyl steroid for use in treating major … |
2022-4-29 |
2022-11-03 |
|
| Neuroactive steroid for use in treating major depressive disorder and … |
2022-4-29 |
2022-11-03 |
|
| C7, c12 and c16 substituted neuroactive steroids and their methods of use |
2022-4-26 |
2022-7-12 |
|
| Neuroactive steroids, compositions, and uses thereof |
2022-4-25 |
2022-6-01 |
|
| Treatment of essential tremor |
2022-4-12 |
2023-2-01 |
|
| Treatment of essential tremor |
2022-4-11 |
2022-10-20 |
|
| OXYESTEROLS AND METHODS FOR THEIR USE |
2022-4-06 |
2023-8-02 |
|
| A 19-nor c3,3-disubstituted c21-n-pyrazolyl steroid for the treatment of major … |
2022-3-17 |
2023-9-21 |
|
| Neuroactive steroids, compositions, and uses thereof |
2022-3-09 |
2022-3-31 |
|
| Use of neuroactive steroids for the treatment of sexual dysfunction |
2022-1-27 |
2023-10-03 |
|
| Use of neuroactive steroids for treatment of sexual dysfunction |
2022-1-27 |
2023-8-01 |
|
| Use of neuroactive steroid for treatment of sexual dysfunction |
2022-1-27 |
2022-8-25 |
|
| C7 substituted oxysterols and methods as nmda modulators |
2022-1-13 |
2022-3-04 |
|
| Compositions and methods for treating cns disorders |
2021-12-20 |
2022-2-01 |
|
| Compositions and methods for treating cns disorders |
2021-12-20 |
2022-2-01 |
|
| Compositions and methods for treating cns disorders |
2021-11-25 |
2022-9-16 |
|
| COMPOSITIONS AND METHODS OF TREATMENT OF CNS DISORDERS |
2021-11-25 |
2023-2-22 |
|
| Compositions and methods for treating CNS disorders |
2021-11-22 |
2023-9-01 |
|
| Oxysterols and methods of use thereof |
2021-9-17 |
2021-10-14 |
|
| Neuroactive steroids, compositions, and uses thereof |
2021-9-13 |
2023-10-10 |
2023-10-10 |
| Compounds and methods of their use |
2021-8-13 |
2021-12-02 |
|
| NEUROACTIVE STEROIDS AND COMPOSITIONS THEREOF |
2021-6-24 |
2022-10-05 |
|
| 3.alpha.-hydroxy-17.beta.-amide neuroactive steroids and compositions thereof |
2021-6-20 |
2021-8-31 |
|
| STERILE AQUEOUS SOLUTION OF NEUROACTIVE AGENT |
2021-5-12 |
2022-12-21 |
|
| Neuroactive steroids, compositions, and uses thereof |
2021-4-16 |
2021-5-28 |
|
| Neuroactive steroids substituted in position 10 with a cyclic group for use in … |
2021-4-08 |
2021-5-31 |
|
| USE OF AGENTS FOR THE TREATMENT OF RESPIRATORY CONDITIONS |
2021-3-25 |
2022-9-07 |
|
| Neuroactive steroids and their methods of use |
2021-3-18 |
2023-6-15 |
|
| COMPOSITIONS AND METHODS FOR THE THERAPEUTIC TREATMENT OF CNS DISORDERS |
2021-3-02 |
2022-5-27 |
|
| Neuroactive steroids, compositions, and uses thereof |
2021-1-26 |
2021-5-14 |
|
| Compositions and methods for treating cns disorders |
2020-12-28 |
2021-4-22 |
|
| 19-nor neuroactive steroids and methods of use thereof |
2020-10-09 |
2021-5-13 |
|
| 19-nor neuroactive steroids and use methods thereof |
2020-8-11 |
2020-11-05 |
|
| Compounds for treating cns disorders |
2020-6-29 |
2020-12-30 |
|
| COMPOSITIONS AND METHODS FOR THE TREATMENT OF CNS DISORDERS |
2020-6-29 |
2021-12-09 |
|
| COMPOSITIONS AND METHODS FOR THE TREATMENT OF CNS DISORDERS |
2020-6-29 |
2021-12-09 |
|
| Compositions and methods for treating cns disorders |
2020-6-22 |
2020-8-31 |
|
| Compositions and methods for treating cns disorders |
2020-6-18 |
2020-8-31 |
|
| Oxysterols and methods of use thereof |
2020-6-16 |
2021-2-11 |
|
| Neuroactive steroids and compositions thereof. |
2020-5-29 |
2023-8-24 |
|
| COMPOUNDS, COMPOSITIONS AND METHODS OF USE |
2020-5-26 |
2021-11-17 |
|
| 3-ALPHA-HYDROXY-17-BETA-AMIDE NEUROACTIVE STEROIDS AND COMPOSITIONS THEREOF |
2019-12-20 |
2021-9-28 |
|
| NEUROACTIVE STEROIDS AND COMPOSITIONS THEREOF |
2019-12-20 |
2021-8-11 |
|
| Neuroactive steroids and their methods of use |
2019-10-21 |
2020-8-01 |
|
| 19-nor c3, 3-disubstituted c21-c-bound heteroaryl steroids and methods of use … |
2019-7-10 |
2020-1-16 |
|
| A C21-N-PYRAZOLYL 19-NOR C3,3-DISUSTITUTED STEROID AND METHODS OF USE OF THE … |
2019-6-12 |
2021-1-27 |
|
| COMPOSITIONS AND METHODS FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS |
2019-1-14 |
2021-8-04 |
|